Investor insights
Sectors invested in
high-risk myelodysplastic syndromes1
Immune Thrombocytopenia1
Rare Diseases1
Clinical Trials1
chronic inflammatory demyelinating polyneuropathy1
Oncology1
Immunology1
Immunotherapy1
Myasthenia Gravis1
Autoimmune diseases1
Pemphigus Vulgaris1
Biotechnology1
Acute Myeloid Leukemia1
Therapeutics1
Antibody based medicines1
Funding rounds participated in
$33M sweet spot round size
Most of their 1 investments are in rounds between $33M and $33M
Basic info
Industry
financial services
Date founded
2011
Investments made
a
argenx raised $33M on June 3, 2016
Investors: Aquila Capital, DAFNA Capital Management, LLC, MPM Capital and Burrage Capital Management